development of monoclonal antibodies and new methods for preparing hyperimmune globulins has produced forms of intervention that must be tested by clinical trials , but not all patients may benefit from augmentation of circulating antibodies to p. aeruginosa .
C0003250
monoclonal antibodies
C0003241
antibodies